Egor Kulkov (#907)
- $ 5 B
- Pharmaceuticals
- Russia
- M
- 54 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Egor Kulkov created Pharmstandard together with Viktor Kharitonin, Roman Abramovich and others by combining five factories bought from ICN Pharmaceuticals in 2003. Kulkov and Kharitonin bought out their partners in 2008. Kulkov still has a stake in, and sits on the board of, Pharmstandard, now Russia's leading pharmaceutical firm. The partners also have stakes in Russian pharma firms OTCPharm, Biocad and Generium, one of the makers of the Sputnik V covid vaccine. Kulkov is also a shareholder of British medical technology firm CMR Surgical, which makes the surgical robotic system Versius.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Egor Kulkov’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Egor Kulkov’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $4.7B
(May 4, 2026)
© Iconic Billionaires